Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2017-A03135-48 | Other Identifier | ID-RCB number, ANSM |
Not provided
Not provided
sponsor decision, COVID
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is an autosomal recessive disease caused by mutations in the autoimmune regulator (AIRE) gene, characterized by the clinical triad of chronic mucocutaneous candidiasis (CMC), hypoparathyroidism, and adrenal insufficiency. CMC can be complicated by systemic candidiasis or oral squamous cell carcinomas (SCCs) and may lead to death. The role of chronic Candida infection in the etiopathogenesis of oral SCC is unclear. Long term use of fluconazole lead to emergence of C. albicans strains with azoles decreased susceptibility. CMC is associated with an impaired Th17 cell response, however, it remains unclear whether decreased serum IL-17 and IL-22 levels are related to a defect in cytokine production or to neutralizing autoantibodies resulting from mutations in the AIRE gene
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 APS 1 | Patients with a APS type 1 whose molecular diagnosis (mutation of the AIRE gene) has been established in the diagnosis of the disease, regardless of their mycological status (history of mycosis) or the presence of antifungal treatment. | ||
| Group 2 APS2 | Patients with APS type 2: - with adrenal insufficiency for 50% of them. - a delay of two weeks after stopping antifungal or antibiotic treatment in patients is to be respected. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| the frequency of appearance of Candida yeast strains | the frequency of appearance of Candida yeast strains found in mycological samples from both urinary and oral patients. | Baseline: one session |
Not provided
Not provided
Inclusion Criteria:
For both of groups, inclusion criteria are :
Inclusion criteria specific to group 1: Patients with a APS type 1 whose molecular diagnosis (mutation of the AIRE gene) has been established in the diagnosis of the disease, regardless of their mycological status (history of mycosis) or the presence of antifungal treatment.
Inclusion criteria specific to group 2 : Patients with APS type 2: - with adrenal insufficiency for 50% of them. - a delay of two weeks after stopping antifungal or antibiotic treatment in patients is to be respected.
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients will be included during their routine follow-up for adrenal insufficiency or hypoparathyroidism in the endocrinology department of the University Hospital of Lille, in adult or pediatric endocrinology.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marie-Christine VANTYGHEM, MD,PhD | University Hospital, Lille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hop Claude Huriez Chu Lille | Lille | 59037 | France |
Not provided
| ID | Term |
|---|---|
| D016884 | Polyendocrinopathies, Autoimmune |
| D002178 | Candidiasis, Chronic Mucocutaneous |
| ID | Term |
|---|---|
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D002177 | Candidiasis |
Not provided
Not provided
Not provided
Not provided
Not provided
| D009181 |
| Mycoses |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D003881 | Dermatomycoses |
| D012874 | Skin Diseases, Infectious |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |